Bio Medica Laboratories Flags Rs 2.04 Crore Excess IPO Fund Use

CARE monitoring report for H1FY27 flags 25-50% deviation in Rs47.19cr IPO use: GCP Rs9.09cr vs Rs7.05cr breaching SEBI cap, loan Rs6.54cr vs Rs6.50cr, Rs2.21cr of Rs28.50cr facility spend included GST. No shareholder approval; board to restore Rs2.28cr by Nov 30. Context: echoes past compliance lapses.